called “A recombinant new coronavirus vaccine using human replication-deficient adenovirus as a vector” (application number: 202010193587.8), which strengthens the faith for people to win the battle
called “A recombinant new coronavirus vaccine using human replication-deficient adenovirus as a vector” (application number: 202010193587.8), which strengthens the faith for people to win the battle
found Pfizer and BioNTech are infringing Moderna’s EP 949 with their COVID-19 vaccine Comirnaty and owe the US company damages. However, High Court judge Richard Meade also declared EP 565 invalid. An
March 5 - Pfizer (PFE.N) and BioNTech (22UAy.DE) won a round in their legal battle with Moderna (MRNA.O) over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two
total 1 pages, 4 items